Lucid Diagnostics Inc. (BOATS:LUCD) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of series C Convertible Preferred Stock Closed: US$15M raised · US$1,000 a share Buyers: Holders of a majority of the Company's 12.0% senior secured convertible notes due 2029 Use of proceeds: To accelerate near-term commercial operations and for working capital and general corporate purposes | Oct 22, 2026 |
| Registered direct offering of common shares Closed: US$18M raised · US$1 a share · Canaccord Genuity LLC +1 Dealers: Canaccord Genuity LLC (co-lead), BTIG, LLC (co-lead) Buyers: fundamental institutional investor ($15 million investment) Use of proceeds: Working capital and general corporate purposes | Apr 24, 2026 |
| Public offering of common stock Closed: US$26.9M raised · US$1 a share · Canaccord Genuity LLC +2 Dealers: Canaccord Genuity LLC (co-lead), BTIG, LLC (co-lead), Maxim Group LLC Use of proceeds: Working capital and general corporate purposes | Sep 11, 2025 |
| Public offering of common stock Closed: US$16.1M raised | May 14, 2025 |
| Registered direct offering of shares of common stock Closed: US$15.3M raised · US$1.1 a share · Canaccord Genuity Dealers: Canaccord Genuity (lead) Use of proceeds: Working capital and other general corporate purposes | Mar 5, 2025 |
| Five-year convertible notes Closed: US$21.95M raised Use of proceeds: $3.61 million used to retire existing convertible debt; remainder adds cash to extend runway past reimbursement milestones | Dec 3, 2024 |